Literature DB >> 16286598

Clinical trials in cardiovascular medicine in an era of marginal benefit, bias, and hyperbole.

Joseph Loscalzo.   

Abstract

Mesh:

Year:  2005        PMID: 16286598     DOI: 10.1161/CIRCULATIONAHA.105.594614

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

Review 1.  Applications of grayscale and radiofrequency intravascular ultrasound to image atherosclerotic plaque.

Authors:  Somjot S Brar; Gary S Mintz; Akiko Maehara; Gregg W Stone
Journal:  J Nucl Cardiol       Date:  2010-10       Impact factor: 5.952

2.  The impact of health insurance mandates on drug innovation: evidence from the United States.

Authors:  Natalie Chun; Minjung Park
Journal:  Eur J Health Econ       Date:  2013-04

3.  Impact of medical therapy on atheroma volume measured by different cardiovascular imaging modalities.

Authors:  Mohamad C N Sinno; Mouaz Al-Mallah
Journal:  Cardiol Res Pract       Date:  2010-07-01       Impact factor: 1.866

4.  Strategies to reverse atherosclerosis: an imaging perspective.

Authors:  Jason B Thompson; Michael Blaha; Jon R Resar; Roger S Blumenthal; Milind Y Desai
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-08

5.  Are component endpoints equal? A preference study into the practice of composite endpoints in clinical trials.

Authors:  Melissa C W Vaanholt; Marlies M Kok; Clemens von Birgelen; Marieke G M Weernink; Janine A van Til
Journal:  Health Expect       Date:  2018-08-14       Impact factor: 3.377

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.